PATENT CLAIM ANALYSIS

Application Number: 15867201
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "548000"]

Abstract:
Compositions for use in treating and/or alleviating a symptom of inflammatory bowel disease, colitis, and/or enterocolitis in a subject in need thereof are disclosed. The composition comprises a therapeutically effective amount of an anthraquinone derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable vehicle. In one embodiment, the composition comprises diacerein. Also disclosed is a first composition comprising an anthraquinone derivative selected from the group consisting of diacerein, aloe-emodin, emodin, and rhein, and a first pharmaceutically acceptable vehicle; and a second composition comprising mesalazine, and a second pharmaceutically acceptable vehicle, in combination for use in treating and/or alleviating a symptom of inflammatory bowel disease, colitis, and/or enterocolitis.

Claim (Index 16):
The method of  claim 10 , wherein a human daily dose of diacerein, aloe-emodin, emodin, or rhein is no less than 30 mg/kg\u00d7(0.020 in kg/human weight in kg) 0.33 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 2.21053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10511612', '10618148', '10107080', '15320827', '14786754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7547814746325368
- 35 USC 102 Novelty (BERT): 0.5034500219529736
- Combined Prediction Score: 0.7296483293645805
- Mean Citation Score: 219.429642
- Max Citation Score: 226.04909
- Similarity Product: 146.6312806893003

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test